Chronic myelomonocytic leukemia coexisting with monoclonal gammopathy: concomitant response to azacitidine of both disorders

Ann Hematol. 2015 Oct;94(10):1753-4. doi: 10.1007/s00277-015-2431-y. Epub 2015 Jun 20.

Authors

Pasquale Niscola¹, Agostina Siniscalchi, Andrea Tendas, Laura Scaramucci, Stefano Fratoni, Paolo de Fabritiis, Tommaso Caravita

Affiliation

¹ Hematology Unit and Pathology Department, Sant'Eugenio Hospital, Piazzale dell'Umanesimo 10, 00144, Rome, Italy, pniscola@gmail.com.

PMID: 26088814
DOI: 10.1007/s00277-015-2431-y

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Antimetabolites, Antineoplastic / therapeutic use*
Azacitidine / therapeutic use*
Female
Humans
Leukemia, Myelomonocytic, Chronic / complications*
Leukemia, Myelomonocytic, Chronic / diagnosis
Leukemia, Myelomonocytic, Chronic / drug therapy*
Male
Paraproteinemias / complications*
Paraproteinemias / diagnosis
Paraproteinemias / drug therapy*
Treatment Outcome

Substances

Antimetabolites, Antineoplastic
Azacitidine